Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor AI/II
S Kuchibhotla, D Vanegas, DJ Kennedy… - Cardiovascular …, 2008 - academic.oup.com
S Kuchibhotla, D Vanegas, DJ Kennedy, E Guy, G Nimako, RE Morton, M Febbraio
Cardiovascular research, 2008•academic.oup.comAims The role of scavenger receptors in atherogenesis is controversial as a result of
conflicting reports and a recent hypothesis suggesting that scavenger receptor absence
would enhance the pro-inflammatory, pro-atherogenic milieu. This study addresses the
effect of combined absence of scavenger receptors CD36 and SRA I/II on atherosclerosis
lesion development in the apolipoprotein E knock-out (apoE°) model. Methods We created
background-related strains of apoE°, scavenger receptor AI/II knock-out (SRA°)/apoE° …
conflicting reports and a recent hypothesis suggesting that scavenger receptor absence
would enhance the pro-inflammatory, pro-atherogenic milieu. This study addresses the
effect of combined absence of scavenger receptors CD36 and SRA I/II on atherosclerosis
lesion development in the apolipoprotein E knock-out (apoE°) model. Methods We created
background-related strains of apoE°, scavenger receptor AI/II knock-out (SRA°)/apoE° …
Aims
The role of scavenger receptors in atherogenesis is controversial as a result of conflicting reports and a recent hypothesis suggesting that scavenger receptor absence would enhance the pro-inflammatory, pro-atherogenic milieu. This study addresses the effect of combined absence of scavenger receptors CD36 and SRA I/II on atherosclerosis lesion development in the apolipoprotein E knock-out (apoE°) model.
Methods
We created background-related strains of apoE°, scavenger receptor A I/II knock-out (SRA°)/apoE°, CD36 knock-out (CD36°)/apoE°, and CD36°/SRA°/apoE° mice that were >99% C57Bl/6. Four-week-old mice were fed a Western diet for 12 weeks and were assessed for lesion burden/morphology, risk factors for atherosclerosis, inflammatory mediators, and macrophage function.
Results
There was a 61 and 74% decrease in total aortic lesion area in CD36°/apoE° males and females, respectively, compared with apoE° controls. The absence of SRA was protective (32% decrease in lesion) in female mice. The combined absence of CD36 and SRA provided no further protection in either gender. Macrophages from mice lacking CD36 had decreased pro-inflammatory characteristics and less migration to a pro-inflammatory stimulus. Plasma levels of cytokines/chemokines showed that CD36°/apoE° and CD36°/SRA°/apoE° mice had a less pro-inflammatory phenotype compared with apoE° and SRA°/apoE° mice. Oblivious mice in the apoE° background ruled out potential ‘passenger gene’ effects in the case of CD36.
Conclusion
These results provide new insights into the pro-atherogenic mechanisms of CD36 by implicating processes other than modified lipoprotein uptake.
Oxford University Press